N-Nitroso Moexipril | CAS 1026879-47-9 - Request Quote
N-Nitroso Moexipril
| SZ CAT No: | SZ-M160002 |
| CAS No | 1026879-47-9 |
| Mol.F. | C27H33N3O8 |
| Mol.Wt. | 527.6 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
N-Nitroso Moexipril is chemically (S)-2-(N-((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)-N-nitroso-L-alanyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid. N-Nitroso Moexipril is supplied with detailed characterization data compliant with regulatory guideline. N-Nitroso Moexipril can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Moexipril.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1026879-47-9
Purchase 1026879-47-9
Order 1026879-47-9
Enquire 1026879-47-9
price of 1026879-47-9
1026879-47-9 Supplier
1026879-47-9 Manufacturer
1026879-47-9 Exporter
buy high quality N-Nitroso Moexipril
Purchase N-Nitroso Moexipril
N-Nitroso Moexipril suppliers
N-Nitroso Moexipril manufacturers
N-Nitroso Moexipril price
Order N-Nitroso Moexipril
Enquire N-Nitroso Moexipril
N-Nitroso Moexipril cost
N-Nitroso Moexipril Supplier
N-Nitroso Moexipril Distributor
N-Nitroso Moexipril for Method Validation
Moexipril Reference Standard
N-Nitroso Moexipril for ANDA Filing
N-Nitroso Moexipril for Forced Degradation Studies
N-Nitroso Moexipril Identification Standards
N-Nitroso Moexipril for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


